« Back to Record
Asselah, T., Alami, N. N., Moreno, C., Pol, S., Karatapanis, S., Gschwantler, M., Horsmans, Y., Elefsiniotis, I., Larrey, D., Ferrari, C., Rizzetto, M., Orlandini, A., Calleja, J. L. U. J., Bruno, S., Schnell, G., Qaqish, R. R., Redman, R., Pilot-Matias, T., Kopecky-Bromberg, S., Yu, Y., & Mobashery, N. (2019). Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II). Health Science Reports, 2(3), e92. doi:10.1002/hsr2.92
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/307490



